Table 1.
Clinical data according to the P and NP phenotypesa
| Parameter | NP Group(n = 25) | P Group(n = 21) | P |
|---|---|---|---|
| Age of recipient (yr; mean ± SD) | 46.2 ± 1.88 | 44.00 ± 1.60 | 0.30 (NS) |
| Cold ischemia time (h; mean ± SD) | 25.4 ± 1.40 | 26.19 ± 1.60 | 0.58 (NS) |
| HLA antibodies before transplantation (%) | 24 | 17 | 0.25 (NS) |
| No. of HLA mismatch (mean ± SD) | 2.25 ± 0.14 | 2.50 ± 0.16 | 0.70 (NS) |
| Induction therapy | 0.70 (NS) | ||
| IL-2R | 19 | 16 | |
| ATG | 5 | 3 | |
| no induction | 1 | 2 | |
| Maintenance of IS regimen | 0.20 (NS) | ||
| CsA + AZA or MMF + steroids | 5 | 6 | |
| Tac + AZA or MMF + steroids | 20 | 15 | |
| Delayed graft function (%) | 35 | 32 | 0.90 (NS) |
| Time to BL changes (d; median) | 36.52 | 52.20 | 0.09 (NS) |
a
ATG, antithymocyte globulin; MMF, mycophenolate mofetil; CsA, cyclosporine; Tac, tacrolimus.